VP, Global Disease Area Lead
SpringWorks Therapeutics Inc
Allison Lim is a graduate of Virginia Tech where she obtained a BS in Biology and the University of North Carolina where she obtained a PharmD. Allison began her career in industry nearly 20 years ago and has subsequently led the development of a number of novel drug products for the treatment of rare diseases. Her areas of focus have included rare cancers from early stage clinical through the global approval process and launch. Currently she is the VP, Global Disease Area lead with SpringWorks Therapeutics, Inc. overseeing the development of nirogacestat through the NDA submission and review process.
